[
  {
    "title": "卫信康(603676.SH)：高管翁自忠减持量过半 累计减持15万股",
    "href": "http://stock.jrj.com.cn/2022/12/29153437246210.shtml",
    "datetime": "2022-12-29 15:34:54",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：累计收到政府补助2112.20万元",
    "href": "http://stock.jrj.com.cn/2022/12/27172537240898.shtml",
    "datetime": "2022-12-27 17:25:02",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：副总经理翁自忠拟减持不超26.25万股",
    "href": "http://stock.jrj.com.cn/2022/11/25164737167092.shtml",
    "datetime": "2022-11-25 16:47:05",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：减持数过半 董事陈仕恭累计减持9.47万股",
    "href": "http://stock.jrj.com.cn/2022/11/21164037154486.shtml",
    "datetime": "2022-11-21 16:40:50",
    "code": "603676"
  },
  {
    "title": "卫信康股东周小兵减持14.98万股 套现241.63万 2022年前三季度公司净利1.51亿",
    "href": "http://stock.jrj.com.cn/2022/11/15205237141709.shtml",
    "datetime": "2022-11-15 20:52:57",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：副总经理周小兵拟终止减持计划 已减持14.98万股",
    "href": "http://stock.jrj.com.cn/2022/11/15172837140747.shtml",
    "datetime": "2022-11-15 17:28:26",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：65万股限制性股票将解锁、上市流通",
    "href": "http://stock.jrj.com.cn/2022/11/10214437129198.shtml",
    "datetime": "2022-11-10 21:44:03",
    "code": "603676"
  },
  {
    "title": "卫信康：京卫信康合伙企业拟减持不超过3%股份",
    "href": "http://stock.jrj.com.cn/2022/11/09170237124365.shtml",
    "datetime": "2022-11-09 17:02:36",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：京卫信康合伙企业拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2022/11/09165637124347.shtml",
    "datetime": "2022-11-09 16:56:45",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：第三季度净利增65.38%至4801.58万元",
    "href": "http://stock.jrj.com.cn/2022/10/26194437086945.shtml",
    "datetime": "2022-10-26 19:44:33",
    "code": "603676"
  },
  {
    "title": "【龙虎榜】卫信康9月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/09/06180536977570.shtml",
    "datetime": "2022-09-06 18:05:20",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：子公司获得注射用多种维生素(13)(10/3)药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/09/05181036974478.shtml",
    "datetime": "2022-09-05 18:10:08",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：上半年实现净利润1.03亿元 同比增长93.10%",
    "href": "http://stock.jrj.com.cn/2022/08/22180636922265.shtml",
    "datetime": "2022-08-22 18:06:42",
    "code": "603676"
  },
  {
    "title": "卫信康：持股5%以上股东钟丽娟所持600万股解除质押",
    "href": "http://stock.jrj.com.cn/2022/07/22174336836341.shtml",
    "datetime": "2022-07-22 17:43:51",
    "code": "603676"
  },
  {
    "title": "【龙虎榜】卫信康7月15日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/15180836816623.shtml",
    "datetime": "2022-07-15 18:08:33",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)一字涨停 上半年净利润预增85%-105%",
    "href": "http://stock.jrj.com.cn/2022/07/13114636806770.shtml",
    "datetime": "2022-07-13 11:46:20",
    "code": "603676"
  },
  {
    "title": "卫信康2022年上半年预计净利9865.14万-1.09亿 同比增加85%-105% 产品销量增长",
    "href": "http://stock.jrj.com.cn/2022/07/12175236803998.shtml",
    "datetime": "2022-07-12 17:52:46",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)半年度净利润预增85%-105%、核心产品业务规模扩大",
    "href": "http://stock.jrj.com.cn/2022/07/12153636803254.shtml",
    "datetime": "2022-07-12 15:36:38",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)2021年度权益分派10派1.6元 股权登记日为6月2日",
    "href": "http://stock.jrj.com.cn/2022/05/27200436685910.shtml",
    "datetime": "2022-05-27 20:04:50",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：子公司获得小儿复方氨基酸注射液(19AA-I)药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/05/16154536651285.shtml",
    "datetime": "2022-05-16 15:45:59",
    "code": "603676"
  },
  {
    "title": "卫信康2021年净利9591.11万同比增长64.16% 董事长张勇薪酬130万",
    "href": "http://stock.jrj.com.cn/2022/05/04155036556904.shtml",
    "datetime": "2022-05-04 15:50:53",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：京卫信康合伙企业已减持1.76%股份",
    "href": "http://stock.jrj.com.cn/2022/03/22153834860636.shtml",
    "datetime": "2022-03-22 15:38:26",
    "code": "603676"
  },
  {
    "title": "卫信康：1000万元理财产品到期赎回 获得理财收益约7.88万元",
    "href": "http://stock.jrj.com.cn/2022/03/17164234839537.shtml",
    "datetime": "2022-03-17 16:42:14",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：盐酸多巴胺注射液上市申请获CDE受理",
    "href": "http://stock.jrj.com.cn/2022/01/24153934204287.shtml",
    "datetime": "2022-01-24 15:39:37",
    "code": "603676"
  },
  {
    "title": "卫信康：预计2021年度扣非净利润同比增长90%-115%",
    "href": "http://stock.jrj.com.cn/2022/01/20200034179748.shtml",
    "datetime": "2022-01-20 20:00:25",
    "code": "603676"
  },
  {
    "title": "卫信康2021年预计净利增加2921万-4382万同比增加50%-75% 业务规模扩大",
    "href": "http://stock.jrj.com.cn/2022/01/20183034179411.shtml",
    "datetime": "2022-01-20 18:30:06",
    "code": "603676"
  },
  {
    "title": "卫信康：核心产品规模扩大、新产品逐渐放量 2021年净利同比预增50%到75%",
    "href": "http://stock.jrj.com.cn/2022/01/20163034178777.shtml",
    "datetime": "2022-01-20 16:30:22",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：2021年度净利预增50%-75%",
    "href": "http://stock.jrj.com.cn/2022/01/20153634178249.shtml",
    "datetime": "2022-01-20 15:36:13",
    "code": "603676"
  },
  {
    "title": "卫信康股东京卫信康合伙企业减持1225.41万股 套现1.02亿 第三季度公司净利2903.35万",
    "href": "http://stock.jrj.com.cn/2022/01/12201934151214.shtml",
    "datetime": "2022-01-12 20:19:35",
    "code": "603676"
  },
  {
    "title": "【龙虎榜】卫信康1月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/12180834150721.shtml",
    "datetime": "2022-01-12 18:08:52",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：提前终止减持计划 京卫信康合伙企业已减持2.81%股份",
    "href": "http://stock.jrj.com.cn/2022/01/12174634150517.shtml",
    "datetime": "2022-01-12 17:46:02",
    "code": "603676"
  },
  {
    "title": "【龙虎榜】卫信康1月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/11180934146939.shtml",
    "datetime": "2022-01-11 18:09:04",
    "code": "603676"
  },
  {
    "title": "卫信康换届选举并聘任高级管理人员 第三季度公司净利2903.35万",
    "href": "http://stock.jrj.com.cn/2022/01/07204534134943.shtml",
    "datetime": "2022-01-07 20:45:45",
    "code": "603676"
  },
  {
    "title": "卫信康第三家全资子公司取得《药品生产许可证》",
    "href": "http://stock.jrj.com.cn/2022/01/05194634126013.shtml",
    "datetime": "2022-01-05 19:46:33",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：持股5%以上股东2021年12月24日至12月30日减持1%股份",
    "href": "http://stock.jrj.com.cn/2022/01/03161134109833.shtml",
    "datetime": "2022-01-03 16:11:20",
    "code": "603676"
  },
  {
    "title": "卫信康：多种维生素注射液(13)境内生产药品注册申请获受理",
    "href": "http://stock.jrj.com.cn/2021/12/28160534076406.shtml",
    "datetime": "2021-12-28 16:05:35",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：京卫信康合伙企业已累计减持1.56%的股份",
    "href": "http://stock.jrj.com.cn/2021/12/28154434076248.shtml",
    "datetime": "2021-12-28 15:44:07",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：多种维生素注射液(13)境内生产药品注册申请获受理",
    "href": "http://stock.jrj.com.cn/2021/12/28154234076241.shtml",
    "datetime": "2021-12-28 15:42:06",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：天津京卫信康及其一致行动人持股比例由73.28%减至70.19%",
    "href": "http://stock.jrj.com.cn/2021/12/22182934048281.shtml",
    "datetime": "2021-12-22 18:29:09",
    "code": "603676"
  },
  {
    "title": "卫信康全资孙公司取得《药品生产许可证》 研发生产销售一体化布局再添一子",
    "href": "http://stock.jrj.com.cn/2021/11/25204833920373.shtml",
    "datetime": "2021-11-25 20:48:35",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：全资孙公司洋浦京泰取得药品生产许可证(Bh)",
    "href": "http://stock.jrj.com.cn/2021/11/25172333919400.shtml",
    "datetime": "2021-11-25 17:23:55",
    "code": "603676"
  },
  {
    "title": "卫信康股权激励授予圆满完成 未来两年收入与盈利有望实现稳健增长",
    "href": "http://stock.jrj.com.cn/2021/11/17195633867633.shtml",
    "datetime": "2021-11-17 19:56:59",
    "code": "603676"
  },
  {
    "title": "卫信康：使用2000万元暂时闲置募集资金购买理财产品",
    "href": "http://stock.jrj.com.cn/2021/11/16170133860971.shtml",
    "datetime": "2021-11-16 17:01:11",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)第三季度净利润2903.35万元 同比增长83.93%",
    "href": "http://stock.jrj.com.cn/2021/10/28193233771460.shtml",
    "datetime": "2021-10-28 19:32:49",
    "code": "603676"
  },
  {
    "title": "卫信康：使用3000万元暂时闲置募集资金购买理财产品",
    "href": "http://stock.jrj.com.cn/2021/10/15164733698928.shtml",
    "datetime": "2021-10-15 16:47:09",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)及子公司累计收到政府补助1649.23万元",
    "href": "http://stock.jrj.com.cn/2021/09/29182033537534.shtml",
    "datetime": "2021-09-29 18:20:26",
    "code": "603676"
  },
  {
    "title": "卫信康股东拟减持不超1303.38万股公司股份 上半年公司净利5332.51万",
    "href": "http://stock.jrj.com.cn/2021/09/10194433416638.shtml",
    "datetime": "2021-09-10 19:44:30",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：赣州京卫信康拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2021/09/10170233415744.shtml",
    "datetime": "2021-09-10 17:02:01",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：子公司撤回门冬氨酸鸟氨酸注射液等药品注册申请",
    "href": "http://stock.jrj.com.cn/2021/09/09173133410210.shtml",
    "datetime": "2021-09-09 17:31:04",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：钟丽娟解押900万股及质押1100万股",
    "href": "http://stock.jrj.com.cn/2021/09/06180233393308.shtml",
    "datetime": "2021-09-06 18:02:30",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：京卫信康取得药品生产许可证(Bh)",
    "href": "http://stock.jrj.com.cn/2021/08/18173433274562.shtml",
    "datetime": "2021-08-18 17:34:55",
    "code": "603676"
  },
  {
    "title": "A股异动 | 卫信康(603676.SH)涨停创逾3个月新高 中期净利同比增81%",
    "href": "http://stock.jrj.com.cn/2021/08/18104833272393.shtml",
    "datetime": "2021-08-18 10:48:22",
    "code": "603676"
  },
  {
    "title": "卫信康2021年半年度净利5332.51万元 同比净利增加81.33%",
    "href": "http://stock.jrj.com.cn/2021/08/17182033268041.shtml",
    "datetime": "2021-08-17 18:20:07",
    "code": "603676"
  },
  {
    "title": "卫信康：半年度净利5332.51万元 同比增长81%",
    "href": "http://stock.jrj.com.cn/2021/08/17161533266992.shtml",
    "datetime": "2021-08-17 16:15:16",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)半年度净利润5332.51万元 同比增长81.33%",
    "href": "http://stock.jrj.com.cn/2021/08/17161333266988.shtml",
    "datetime": "2021-08-17 16:13:42",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：子公司药品亚硒酸钠(原料药)通过药品GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2021/08/12154733242880.shtml",
    "datetime": "2021-08-12 15:47:26",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：实控人张勇质押525万股",
    "href": "http://stock.jrj.com.cn/2021/08/10145533231316.shtml",
    "datetime": "2021-08-10 14:55:20",
    "code": "603676"
  },
  {
    "title": "卫信康股东张勇质押525万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2021/08/09211233227327.shtml",
    "datetime": "2021-08-09 21:12:08",
    "code": "603676"
  },
  {
    "title": "卫信康：2021年第一季度主要产品市场表现良好",
    "href": "http://stock.jrj.com.cn/2021/06/21110932968253.shtml",
    "datetime": "2021-06-21 11:09:34",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：向104名激励对象首次授予限制性股票1178.90万股",
    "href": "http://stock.jrj.com.cn/2021/06/09164632900104.shtml",
    "datetime": "2021-06-09 16:46:53",
    "code": "603676"
  },
  {
    "title": "卫信康：使用暂时闲置募集资金购买理财产品到期赎回并继续购买理财产品",
    "href": "http://stock.jrj.com.cn/2021/06/01154132856897.shtml",
    "datetime": "2021-06-01 15:41:40",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：2020年度拟10派0.95元 6月1日股权登记",
    "href": "http://stock.jrj.com.cn/2021/05/26183932824472.shtml",
    "datetime": "2021-05-26 18:39:53",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)拟推2021年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/05/18194132777748.shtml",
    "datetime": "2021-05-18 19:41:01",
    "code": "603676"
  },
  {
    "title": "卫信康实际控制人张勇质押1500万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2021/05/12190432743490.shtml",
    "datetime": "2021-05-12 19:04:22",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：实控人张勇质押1500万股",
    "href": "http://stock.jrj.com.cn/2021/05/12161632742311.shtml",
    "datetime": "2021-05-12 16:16:35",
    "code": "603676"
  },
  {
    "title": "卫信康2020年净利5842.48万增长4.93%本期期间费用减少 董事长张勇薪酬75万",
    "href": "http://stock.jrj.com.cn/2021/04/29105032478676.shtml",
    "datetime": "2021-04-29 10:50:55",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)一季度净利润1855.6万元 同比增长69.62%",
    "href": "http://stock.jrj.com.cn/2021/04/27222732465941.shtml",
    "datetime": "2021-04-27 22:27:02",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：控股股东解押500万股",
    "href": "http://stock.jrj.com.cn/2021/03/29154432241266.shtml",
    "datetime": "2021-03-29 15:44:33",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：子公司混合糖电解质注射液获批",
    "href": "http://stock.jrj.com.cn/2021/03/25173132216706.shtml",
    "datetime": "2021-03-25 17:31:54",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：混合糖电解质注射液的药品注册申请 变更为“制证完毕-待发批件”",
    "href": "http://stock.jrj.com.cn/2021/03/18155532157144.shtml",
    "datetime": "2021-03-18 15:55:43",
    "code": "603676"
  },
  {
    "title": "卫信康：公司纳入国家医保目录的6个药品均属于乙类",
    "href": "http://stock.jrj.com.cn/2021/01/07171431648701.shtml",
    "datetime": "2021-01-07 17:14:22",
    "code": "603676"
  },
  {
    "title": "卫信康(603676.SH)：注射用多种维生素(12)纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2020/12/28181031587345.shtml",
    "datetime": "2020-12-28 18:10:08",
    "code": "603676"
  },
  {
    "title": "卫信康：公司将继续努力完善营销体系建设",
    "href": "http://stock.jrj.com.cn/2020/12/22105231543415.shtml",
    "datetime": "2020-12-22 10:52:19",
    "code": "603676"
  },
  {
    "title": "卫信康前三季度净利4519.28万增长1.79% 研发费用下滑",
    "href": "http://stock.jrj.com.cn/2020/10/29110731156422.shtml",
    "datetime": "2020-10-29 11:07:55",
    "code": "603676"
  },
  {
    "title": "卫信康2020年上半年净利2940.76万下滑21.67% 销量减少、营业收入下降",
    "href": "http://stock.jrj.com.cn/2020/08/27115930603069.shtml",
    "datetime": "2020-08-27 11:59:06",
    "code": "603676"
  },
  {
    "title": "卫信康上市当年变脸净利已连降3年 中信证券赚4000万",
    "href": "http://stock.jrj.com.cn/2020/06/23070229994890.shtml",
    "datetime": "2020-06-23 07:02:00",
    "code": "603676"
  },
  {
    "title": "卫信康：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/05/26221129770984.shtml",
    "datetime": "2020-05-26 22:11:29",
    "code": "603676"
  },
  {
    "title": "卫信康：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/19073029708375.shtml",
    "datetime": "2020-05-19 07:30:05",
    "code": "603676"
  },
  {
    "title": "卫信康及全资子公司自2019年4月23日以来收到政府补助1415.6万元",
    "href": "http://stock.jrj.com.cn/2020/05/03113429493057.shtml",
    "datetime": "2020-05-03 11:34:40",
    "code": "603676"
  },
  {
    "title": "卫信康第一季度盈利1093.96万同比下滑46.27% 收到政府补助减少",
    "href": "http://stock.jrj.com.cn/2020/05/01133829439536.shtml",
    "datetime": "2020-05-01 13:38:18",
    "code": "603676"
  },
  {
    "title": "卫信康：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/28155029405503.shtml",
    "datetime": "2020-04-28 15:50:32",
    "code": "603676"
  },
  {
    "title": "卫信康：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/28155029405504.shtml",
    "datetime": "2020-04-28 15:50:32",
    "code": "603676"
  },
  {
    "title": "卫信康：第二届董事会第六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/28155029405501.shtml",
    "datetime": "2020-04-28 15:50:32",
    "code": "603676"
  },
  {
    "title": "卫信康：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/28155029405502.shtml",
    "datetime": "2020-04-28 15:50:32",
    "code": "603676"
  },
  {
    "title": "卫信康2019年净利5567.78万较上年同期下滑24.18% 研发费用上涨",
    "href": "http://stock.jrj.com.cn/2020/04/28154329404593.shtml",
    "datetime": "2020-04-28 15:43:27",
    "code": "603676"
  },
  {
    "title": "卫信康使用暂时闲置募集资金4500万元购买理财产品",
    "href": "http://stock.jrj.com.cn/2020/02/20201028864179.shtml",
    "datetime": "2020-02-20 20:10:16",
    "code": "603676"
  },
  {
    "title": "卫信康子公司两项药物获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/03183228625508.shtml",
    "datetime": "2020-01-03 18:32:19",
    "code": "603676"
  },
  {
    "title": "卫信康：子公司获两个药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/03170228625062.shtml",
    "datetime": "2020-01-03 17:02:27",
    "code": "603676"
  },
  {
    "title": "卫信康：子公司获得两个药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/03165628625036.shtml",
    "datetime": "2020-01-03 16:56:00",
    "code": "603676"
  },
  {
    "title": "卫信康：2019年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/11/11224028382220.shtml",
    "datetime": "2019-11-11 22:40:11",
    "code": "603676"
  },
  {
    "title": "卫信康：关于召开2019年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/10/25000128297049.shtml",
    "datetime": "2019-10-25 00:01:27",
    "code": "603676"
  },
  {
    "title": "卫信康：第二届董事会第五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/10/25000128297050.shtml",
    "datetime": "2019-10-25 00:01:27",
    "code": "603676"
  },
  {
    "title": "卫信康：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/25000028296918.shtml",
    "datetime": "2019-10-25 00:00:25",
    "code": "603676"
  },
  {
    "title": "卫信康前三季度盈利4440万 同比下滑31%",
    "href": "http://stock.jrj.com.cn/2019/10/24185128295733.shtml",
    "datetime": "2019-10-24 18:51:27",
    "code": "603676"
  },
  {
    "title": "卫信康2019年上半年盈利3754万 市场管理与推广服务收入增加",
    "href": "http://stock.jrj.com.cn/2019/08/28140428048939.shtml",
    "datetime": "2019-08-28 14:04:05",
    "code": "603676"
  },
  {
    "title": "卫信康：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/28011028044218.shtml",
    "datetime": "2019-08-28 01:10:12",
    "code": "603676"
  },
  {
    "title": "卫信康：第二届董事会第四次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/28011028044217.shtml",
    "datetime": "2019-08-28 01:10:11",
    "code": "603676"
  },
  {
    "title": "卫信康拟使用1.55亿闲置募资认购理财产品",
    "href": "http://stock.jrj.com.cn/2019/08/14080327973234.shtml",
    "datetime": "2019-08-14 08:03:34",
    "code": "603676"
  },
  {
    "title": "卫信康使用1.75亿元投资理财产品的闲置募集资金到期赎回",
    "href": "http://stock.jrj.com.cn/invest/2019/07/12085027830584.shtml",
    "datetime": "2019-07-12 08:50:00",
    "code": "603676"
  },
  {
    "title": "卫信康：子公司获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/05/29161227637645.shtml",
    "datetime": "2019-05-29 16:12:28",
    "code": "603676"
  },
  {
    "title": "卫信康：2018年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/05/24004027614208.shtml",
    "datetime": "2019-05-24 00:40:15",
    "code": "603676"
  },
  {
    "title": "卫信康：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/05/16221027583196.shtml",
    "datetime": "2019-05-16 22:10:05",
    "code": "603676"
  },
  {
    "title": "卫信康一季度净利2036万同比下滑39% 现金流量净额为5260万",
    "href": "http://stock.jrj.com.cn/2019/04/28102627501103.shtml",
    "datetime": "2019-04-28 10:26:48",
    "code": "603676"
  },
  {
    "title": "卫信康去年净利7344万 同比降28% 董事长张勇薪酬70万",
    "href": "http://stock.jrj.com.cn/2019/04/26181027492527.shtml",
    "datetime": "2019-04-26 18:10:25",
    "code": "603676"
  },
  {
    "title": "卫信康：2018年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/26053027485728.shtml",
    "datetime": "2019-04-26 05:30:04",
    "code": "603676"
  },
  {
    "title": "卫信康：2019年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/26053027485729.shtml",
    "datetime": "2019-04-26 05:30:04",
    "code": "603676"
  },
  {
    "title": "卫信康：第二届董事会第二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/26053027485730.shtml",
    "datetime": "2019-04-26 05:30:04",
    "code": "603676"
  },
  {
    "title": "卫信康：关于召开2018年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/04/26053027485727.shtml",
    "datetime": "2019-04-26 05:30:04",
    "code": "603676"
  },
  {
    "title": "卫信康2名董事合计减持25万股 去年上半年营收同比增长59%",
    "href": "http://stock.jrj.com.cn/2019/04/24062027471039.shtml",
    "datetime": "2019-04-24 06:20:40",
    "code": "603676"
  },
  {
    "title": "卫信康：第二届董事会第一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/12/21012026775230.shtml",
    "datetime": "2018-12-21 01:20:02",
    "code": "603676"
  },
  {
    "title": "卫信康：关于召开2018年第三次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/11/29214025422671.shtml",
    "datetime": "2018-11-29 21:40:43",
    "code": "603676"
  },
  {
    "title": "卫信康：第一届董事会第二十二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/11/29214025422670.shtml",
    "datetime": "2018-11-29 21:40:43",
    "code": "603676"
  },
  {
    "title": "卫信康：2018年第二次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/11/12223025335151.shtml",
    "datetime": "2018-11-12 22:30:17",
    "code": "603676"
  },
  {
    "title": "卫信康：2018年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/26005025261158.shtml",
    "datetime": "2018-10-26 00:50:12",
    "code": "603676"
  },
  {
    "title": "卫信康：第一届董事会第二十一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/10/26005025261159.shtml",
    "datetime": "2018-10-26 00:50:12",
    "code": "603676"
  },
  {
    "title": "卫信康：关于召开2018年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/10/26005025261160.shtml",
    "datetime": "2018-10-26 00:50:12",
    "code": "603676"
  },
  {
    "title": "卫信康：小儿注射用多种维生素获药品注册批件",
    "href": "http://stock.jrj.com.cn/2018/09/21202525126178.shtml",
    "datetime": "2018-09-21 20:25:00",
    "code": "603676"
  },
  {
    "title": "卫信康：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/28074025011432.shtml",
    "datetime": "2018-08-28 07:40:13",
    "code": "603676"
  },
  {
    "title": "卫信康：第一届董事会第二十次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/08/28074025011431.shtml",
    "datetime": "2018-08-28 07:40:13",
    "code": "603676"
  },
  {
    "title": "卫信康：关于首次公开发行部分限售股上市流通的公告",
    "href": "http://stock.jrj.com.cn/2018/07/16233024822322.shtml",
    "datetime": "2018-07-16 23:30:09",
    "code": "603676"
  },
  {
    "title": "卫信康：新产品投产成为2018年利润新增长点",
    "href": "http://stock.jrj.com.cn/2018/07/05172324775163.shtml",
    "datetime": "2018-07-05 17:23:00",
    "code": "603676"
  },
  {
    "title": "[卫信康]内蒙古自治区药监局领导来公司考察调研",
    "href": "http://stock.jrj.com.cn/2018/05/18000024559491.shtml",
    "datetime": "2018-05-18 00:00:00",
    "code": "603676"
  },
  {
    "title": "卫信康：2017年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/05/15215024544150.shtml",
    "datetime": "2018-05-15 21:50:06",
    "code": "603676"
  },
  {
    "title": "[卫信康]祝贺全新儿童专用处方药“卫优佳”隆重发布",
    "href": "http://stock.jrj.com.cn/2018/05/04000024493176.shtml",
    "datetime": "2018-05-04 00:00:00",
    "code": "603676"
  },
  {
    "title": "卫信康：2017年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/25003024443604.shtml",
    "datetime": "2018-04-25 00:30:05",
    "code": "603676"
  },
  {
    "title": "卫信康：2018年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/25003024443607.shtml",
    "datetime": "2018-04-25 00:30:05",
    "code": "603676"
  },
  {
    "title": "卫信康：第一届董事会第十七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/04/25003024443605.shtml",
    "datetime": "2018-04-25 00:30:05",
    "code": "603676"
  },
  {
    "title": "卫信康：关于召开2017年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/04/25003024443606.shtml",
    "datetime": "2018-04-25 00:30:05",
    "code": "603676"
  },
  {
    "title": "卫信康2018年一季度大幅增收增利 旗下小儿新品获药品注册批件",
    "href": "http://stock.jrj.com.cn/2018/04/24221524443168.shtml",
    "datetime": "2018-04-24 22:15:00",
    "code": "603676"
  },
  {
    "title": "卫信康2017年盈利10159万元 拟10派0.8元",
    "href": "http://stock.jrj.com.cn/2018/04/24212324442878.shtml",
    "datetime": "2018-04-24 21:23:00",
    "code": "603676"
  },
  {
    "title": "卫信康小儿多种维生素注射液获药品注册批件和新药证书",
    "href": "http://stock.jrj.com.cn/2018/04/24103824439509.shtml",
    "datetime": "2018-04-24 10:38:32",
    "code": "603676"
  },
  {
    "title": "游资抱团炒新卫信康",
    "href": "http://stock.jrj.com.cn/2018/02/01193224047136.shtml",
    "datetime": "2018-02-01 19:32:24",
    "code": "603676"
  },
  {
    "title": "卫信康三连板引爆医药板块 华森制药等多股涨停",
    "href": "http://stock.jrj.com.cn/2017/12/26100123850671.shtml",
    "datetime": "2017-12-26 10:01:10",
    "code": "603676"
  },
  {
    "title": "[卫信康]卫信康助力中国医学科学院肿瘤医院陈莲珍主任 获“齐鲁杯”优秀论文奖",
    "href": "http://stock.jrj.com.cn/2017/11/20000023700021.shtml",
    "datetime": "2017-11-20 00:00:00",
    "code": "603676"
  },
  {
    "title": "[卫信康]热烈祝贺卫信康医药荣获“2017年度十大最具 投资价值医药上市公司”称号",
    "href": "http://stock.jrj.com.cn/2017/11/20000023700025.shtml",
    "datetime": "2017-11-20 00:00:00",
    "code": "603676"
  },
  {
    "title": "[卫信康]西藏卫信康“关爱农牧儿童”筑梦扶贫公益活动走进那曲 爱心捐赠暖人心",
    "href": "http://stock.jrj.com.cn/2017/07/28000023700020.shtml",
    "datetime": "2017-07-28 00:00:00",
    "code": "603676"
  },
  {
    "title": "[卫信康]卫信康成功登陆A股 实现资本市场全新跨越",
    "href": "http://stock.jrj.com.cn/2017/07/24000023700026.shtml",
    "datetime": "2017-07-24 00:00:00",
    "code": "603676"
  },
  {
    "title": "从细分为王到多元崛起 卫信康的卫冕之战悄然打响",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/22043622783718.shtml",
    "datetime": "2017-07-22 04:36:51",
    "code": "603676"
  },
  {
    "title": "卫信康7月21日登陆上交所 晋升西藏第15家A股上市公司",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/21090822779568.shtml",
    "datetime": "2017-07-21 09:08:00",
    "code": "603676"
  },
  {
    "title": "卫信康7月21日上交所上市 定位分析",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/20092122773934.shtml",
    "datetime": "2017-07-20 09:21:58",
    "code": "603676"
  },
  {
    "title": "新股提醒：隆盛科技等2股申购 卫信康中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/13064722741067.shtml",
    "datetime": "2017-07-13 06:47:25",
    "code": "603676"
  },
  {
    "title": "卫信康网上发行最终中签率0.0471% 神器助力防弃购",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/11211422734165.shtml",
    "datetime": "2017-07-11 21:14:33",
    "code": "603676"
  },
  {
    "title": "卫信康7月11日开启申购 拟募资3.5亿投6大项目",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/11093822730328.shtml",
    "datetime": "2017-07-11 09:38:00",
    "code": "603676"
  },
  {
    "title": "新股提醒：卫信康今日申购 凌霄泵业等3股上市交易",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/11064222728870.shtml",
    "datetime": "2017-07-11 06:42:50",
    "code": "603676"
  },
  {
    "title": "[卫信康]卫信康生产中心白医制药党支部开展爱红城、爱企业,助力企业腾飞活动",
    "href": "http://stock.jrj.com.cn/2017/06/29000023700017.shtml",
    "datetime": "2017-06-29 00:00:00",
    "code": "603676"
  },
  {
    "title": "[卫信康]媒体报道:西藏卫信康生产中心白医制药“在创新中实现华丽转身”",
    "href": "http://stock.jrj.com.cn/2017/05/08000023700023.shtml",
    "datetime": "2017-05-08 00:00:00",
    "code": "603676"
  },
  {
    "title": "[卫信康]西藏卫信康携手西藏大学共建“校企合作”实习基地",
    "href": "http://stock.jrj.com.cn/2017/05/05000023700024.shtml",
    "datetime": "2017-05-05 00:00:00",
    "code": "603676"
  },
  {
    "title": "[卫信康]“致知力行”——卫信康2016年终总结暨2017年会隆重召开",
    "href": "http://stock.jrj.com.cn/2017/01/27000023700022.shtml",
    "datetime": "2017-01-27 00:00:00",
    "code": "603676"
  },
  {
    "title": "[卫信康]赢在同心 胜在执行 — 西藏卫信康子公司白医制药2017年主题年会圆满举办",
    "href": "http://stock.jrj.com.cn/2017/01/23000023700019.shtml",
    "datetime": "2017-01-23 00:00:00",
    "code": "603676"
  },
  {
    "title": "[卫信康]西藏卫信康营销中心2016年度工作总结会议",
    "href": "http://stock.jrj.com.cn/2017/01/13000023700018.shtml",
    "datetime": "2017-01-13 00:00:00",
    "code": "603676"
  }
]